Effect of a Sugar-free Isotonic Drink on Different Health Bioparameters
1 other identifier
interventional
240
1 country
1
Brief Summary
Randomized clinical trial in which 160 participants (80 men, 80 women) will be assigned to one of two groups (40 participants per group), to determine the effects of isotonic drink on different health parameters, following published recommendations. Subjects will be electronically randomized by block design into two arms: an experimental group: isotonic drink and a control group (placebo): normal water.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy-volunteers
Started Jan 2024
Typical duration for not_applicable healthy-volunteers
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 14, 2023
CompletedFirst Posted
Study publicly available on registry
December 29, 2023
CompletedStudy Start
First participant enrolled
January 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMarch 25, 2025
March 1, 2025
6 months
December 14, 2023
March 24, 2025
Conditions
Outcome Measures
Primary Outcomes (18)
Body composition
Measurement of body composition using bioimpedance with the Biodyxpert device.
12 weeks
Body composition
Measurement of body composition through anthropometry.
12 weeks
Blood pressure
Measurement of systolic and diastolic blood pressure. Using an OMROM upper arm blood pressure monitor.
12 weeks
Perception of quality of life
Using a Quality of Life Questionnaire (SF36). Quality of Life Questionnaire is a comprehensive questionnaire that covers various attributes of an individuals life. It covers a variety of demographic questions to get better quality data and information before analyzing the quality of life of an individual.The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.
12 weeks
Perceived stress
Measurement of perceived stress using the Perceived Stress Scale (PSS)
12 weeks
BLOOD GLUCOSE
Glucose levels in blood by blood analysis.
12 weeks
BLOOD INSULIN
Insulin levels in blood by blood analysis.
12 weeks
BLOOD LIPID PORFILE
Cholesterol and triglycerides levels in blood.
12 weeks
Specific color of urine
12 weeks
Specific gravity of urine
12 weeks
Minerals in urine
K+ (Potassium), Na+ (Sodium), Mg2+ (Magnesium), Ca2+ (Calcium)
12 weeks
Urinary pH
12 weeks
Mood States Profile
The POMS (Profile of Mood States) questionnaire is a psychological assessment tool widely used to measure mood states. It consists of a series of words or phrases that describe feelings and emotions. Participants are asked to rate each item on a scale, indicating how well it represents their mood over a specific period. The POMS measures six different mood dimensions: Tension-Anxiety, Depression-Dejection, Anger-Hostility, Vigor-Activity, Fatigue-Inertia, and Confusion-Bewilderment. It's commonly used in clinical settings, as well as in research studies, to assess the impact of various treatments or interventions on mood states. The POMS is valued for its sensitivity in detecting mood changes over time and its ability to differentiate between various mood states.
12 weeks
Evaluation of constipation symptoms by the patient
The PAC-SYM (Patient Assessment of Constipation Symptoms) is a self-report questionnaire designed to evaluate the symptoms of constipation from the patient's perspective. It is commonly used in clinical research and practice to assess the severity and impact of constipation symptoms. The questionnaire includes a series of items that ask patients to rate the frequency and severity of their constipation-related symptoms, such as abdominal discomfort, straining, and incomplete bowel movements.
12 weeks
Evaluation of the quality of life of patients with constipation (PAC-QOL)
The PAC-QOL (Patient Assessment of Constipation Quality of Life) questionnaire is a specialized tool designed to assess the quality of life in individuals suffering from constipation. It is a patient-reported outcome measure that focuses on how constipation affects a person's daily life, well-being, and overall health.
12 weeks
Sleep quality
Measurement of sleep quality using the Pittsburgh sleep quality index.
12 weeks
Liver biomarkers
Measurement of liver biomarkers through a blood test; Aspartate aminotransferase (AST or GOT), Alanine aminotransferase (ALT or GPT) and Bilirubin
12 weeks
Microbiome Indices
Microbiome indices through stool sample; Firmicutes/Bacteroidetes, Bacteroides/Prevotella, Enterobacteria/Enterococcus, Clostridium coccoides/perfringens
12 weeks
Secondary Outcomes (1)
Weight
12 weeks
Study Arms (2)
CONTROL GROUP
PLACEBO COMPARATORVolunteer participants who will drink water
ISOTONIC DRINK GROUP
EXPERIMENTALVolunteer participants who will drink Natural isotonic drink based on 20% Atlantic sea water, mixed with lemon and stevia.
Interventions
Intake of natural isotonic drink based on 20% Atlantic sea water, mixed with lemon and stevia.
Eligibility Criteria
You may qualify if:
- men and women aged \>18 years;
- body mass index (BMI) of 18 to 25 kg/m\^2;
You may not qualify if:
- individuals who have taken medication up to 3 months before the start of the study or supplements during the study;
- individuals with a history of gastrointestinal pathology or disorder such as duodenal ulcer, chronic colitis, or chronic inflammatory disease/surgery of the gastrointestinal tract (Crohn\'s disease, ulcerative colitis), celiac disease, or irritable bowel syndrome;
- individuals with serious acute or chronic diseases, treatments, or recent surgery;
- individuals with a report of serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), or gamma-glutamyl transferase (GGT) above the upper limit of the reference interval.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alejandro Martínez Rodríguez
Elche, Alicante, 03203, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants will not be aware that there are other people consuming a different type of drink than theirs. The person analyzing the results will also be unaware. However, the researchers will be aware because they need to control the supply.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full professor
Study Record Dates
First Submitted
December 14, 2023
First Posted
December 29, 2023
Study Start
January 8, 2024
Primary Completion
July 1, 2024
Study Completion
December 31, 2024
Last Updated
March 25, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share